Chehyun Nam

Research Associate

Is this your profile? Click to edit

Publications

ETS1 Orchestrates a Hybrid EMT Program Driving Metastasis and Immune Evasion. Cancer Res. 2026 08 14; 86(16):3932-3950.. View in PubMed
ETS1 Orchestrates a Hybrid EMT Program Driving in vivo Metastasis and Immune Evasion. bioRxiv. 2025 Jul 21.. View in PubMed
Genomic and Single-Cell Analyses Characterize Patient-Derived Tumor Organoids to Enable Personalized Therapy for Head and Neck Squamous Cell Carcinoma. Cancer Res. 2025 07 15; 85(14):2726-2742.. View in PubMed
The MLL3/GRHL2 complex regulates malignant transformation and anti-tumor immunity in squamous cancer. J Exp Med. 2025 Apr 07; 222(4).. View in PubMed
Genomic and single-cell characterization of patient-derived tumor organoid models of head and neck squamous cell carcinoma. bioRxiv. 2024 Jul 02.. View in PubMed
A druggable cascade links methionine metabolism to epigenomic reprogramming in squamous cell carcinoma. Proc Natl Acad Sci U S A. 2024 06 25; 121(26):e2320835121.. View in PubMed
Epigenomic analyses identify FOXM1 as a key regulator of anti-tumor immune response in esophageal adenocarcinoma. Cell Death Dis. 2024 02 19; 15(2):152.. View in PubMed
Treatment for ovarian clear cell carcinoma with combined inhibition of WEE1 and ATR. J Ovarian Res. 2023 Apr 22; 16(1):80.. View in PubMed
Genomic and Epigenomic Characterization of Tumor Organoid Models. Cancers (Basel). 2022 Aug 24; 14(17).. View in PubMed